Skip to main content

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers
	Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers
	Hodges, Nick, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers
	Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers
	Krueger, Karl, Ph.D. [V] karl.krueger@nih.gov		Volunteer \| Cancer Biomarkers
	Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers
	Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers
	Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Program Officer \| Cancer Biomarkers
	Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers
	Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers
	Villanueva, Juan Miguel juan.villanueva@nih.gov	5E630	Program Analyst \| Cancer Biomarkers
	Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers
	Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Pandharipande, Pari Vijay	Ohio State University United States	Precision Management of Cystic Precursors to Pancreatic Cancer	5R01CA237133-06	Matthew Young, Ph.D.
Papadopoulos, Nickolas	Johns Hopkins University United States	Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma Biofluids	5U01CA230691-08
Paulson, Thomas G	Fred Hutchinson Cancer Center United States	The microbiome ecosystem of Barrett's esophagus and progression to cancer	5R21CA259687-02	Matthew Young, Ph.D.
Permuth, Jennifer B	H. Lee Moffitt Cancer Ctr & Res Inst United States	Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology	5R37CA229810-07	Matthew Young, Ph.D.
Pitteri, Sharon	Stanford University United States	Glycosylation and Immune Evasion in Urologic Tumors	5U01CA226051-05
Pozdeyev, Nikita	University Of Colorado Denver United States	Genetic architecture of thyroid cancer and its clinical utility	5R21CA282380-02	Wendy Wang, Ph.D., M.Sc.
Punnen, Sanoj	University Of Miami School Of Medicine United States	The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection	5R01CA272766-03	Matthew Young, Ph.D.
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-11
Rosser, Charles J	Cedars-Sinai Medical Center United States	A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology	5R01CA277810-03	Guillermo Marquez, Ph.D.
Rotemberg, Veronica Miriam	Sloan-Kettering Inst Can Research United States	M-ISIC: A Multimodal Open-Source International Skin Imaging Collaboration Informatics Platform for Automated Skin Cancer Detection	5U24CA264369-04	Guillermo Marquez, Ph.D.
Saenger, Yvonne Margaret	Albert Einstein College Of Medicine United States	Applying pathomics to establish a biosignature for aggressive skin melanoma	5R01CA260375-05	Guillermo Marquez, Ph.D.
Salami, Simpa Samuel	University Of Michigan At Ann Arbor United States	Defining the Biological Arc of Grade Group 1 Prostate Cancer	5R37CA283857-03	Guillermo Marquez, Ph.D.
Salkowski, Lonie	University Of Wisconsin-Madison United States	Defining and Optimizing Critical Interpretation Skills in Screening Mammography to Improve Cancer Detection	5R37CA262110-04	Guillermo Marquez, Ph.D.
Sanda, Martin G	Emory University United States	Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern	5U01CA113913-18	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Schoen, Robert E.	University Of Pittsburgh At Pittsburgh United States	Blood-Based Testing for Advanced Adenoma	5U01CA271884-04	Matthew Young, Ph.D.